Search results
Patients with sporadic breast cancer should be adequately informed about the estimated risks and benefits of undergoing a contralateral prophylactic mastectomy. The CBCRisk may be useful for the counseling of these patients, but it requires validation in larger and prospective cohorts.
21 paź 2022 · Contralateral breast cancer (CBC) is the most common second primary cancer among women diagnosed with first primary invasive breast cancer (BC) [1]. CBC accounts for approximately 40–50% of all new secondary cancers in women with first primary invasive BC and has a potentially less favorable prognosis [2, 3, 4, 5, 6].
3 lis 2020 · We aimed to assess contralateral breast cancer (CBC) risk in patients with ductal carcinoma in situ (DCIS) compared with invasive breast cancer (BC). Women diagnosed with DCIS (N =...
17 gru 2019 · Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the consequent burden of further treatment and potentially less favorable prognosis. We aimed to develop and validate a CBC risk prediction model and evaluate its applicability for clinical decision-making.
2 cze 2022 · This study seeks to determine the risk of SPCs, including contralateral breast cancer (CBCa), in women with early-stage invasive lobular carcinoma (ILC). Methods: The study population consisted of women with BCa diagnosis between 2000-2018 within the NCI Surveillance, Epidemiology, and End Results (SEER v 3.2.9) registry and between 2000-2021 ...
A cancer in the contralateral breast in a woman with a previous or synchronous breast cancer is typically considered to be an independent primary tumor. Emerging evidence suggests that in a small subset of these cases the second tumor represents a metastasis.
3 lis 2020 · Cumulative incidences of invasive contralateral breast cancer (CBC) in patients diagnosed with ductal carcinoma in situ (DCIS), invasive breast cancer (BC) stage I–III, and stage I BC without (neo)adjuvant systemic therapy.
